Introduction and aim of work: Neurocognitive late effects are common sequelae of cancer in children, especially in those who have undergone treatment for brain tumors or in those receiving prophylactic cranial radiation or intrathecal chemotherapy therapy to treat leukemia and non Hodgkin lymphoma (NHL). As NHL represents 8-10% of all malignancies in children between 5-19 years of age (Cairo, 2009) and all NHL children receive intrathecal methotrexate as therapy or prophylaxis so we studied effect of intrathecal methotrexate in NHL treated children in their cognitive function and compare it with normal children, also we studied effect of some risk factors (age at disease onset and number of intrathecal injections) on the affected intelligence subscales and lastly a suitable and applicable model to evaluate neurocognitive function was done.
Introduction
Cognition is the set of all mental abilities and processes related to knowledge: attention, memory & workin g memory, judgement&evaluation, reasoning & "computation", problem solving & decision making, comprehension & production of language, (Anderson and John, 2004). Non-Hodgkin lymphoma (NHL) results from malignant proliferation of cells of lymphocytic lineage. Although malignant lymphomas are generally restricted to lymphoid tissue such as lymph nodes, Peyer's patches and spleen, it is not uncommon to find bone marrow involvement in children. Bone and primary CNS lymphomas are rare presentations (Cairo MS, 2009).
Methotrexate is one of antifolate drugs (Gangjee, 2007). Methotrexate was originally developed and continues to be used for chemotherapy, either alone or in combination with other agents. It is effective for the treatment of a number of cancers including: breast, head and neck, leukemia, lymphoma, lung, osteosarcoma, bladder, and trophoblastic neoplasms (Miller, 2006 
Results
Comparison between cases and controls according to Stanford-Binet Intelligence Scale in the study revealed that the verbal and quantitative sub-scales were significantly better among controls compared to cases(p value .037 in verbal, .018 for quantitative) and the abstract/visual and short term memory were better among controls than cases but not significant (p value in order 0.411,0.265). The total Stanford-Binet Intelligence Scale was significantly higher among controls compared to cases (p value .020). 
Discussion
In a study of adult survivors of childhood non-CNS cancers (ALL-NHL), 13% to 21% of survivors reported impairment in task efficiency, organization, memory, or emotional regulation. This rate of impairment was approximately 50% higher than that reported in the sibling comparison group. Factors such as diagnosis before age 6 years, female gender, cranial radiation therapy, and hearing impediment were associated with more impairment (KadanLottick et al, 2017).
In the present study we choose to study effect of methotrexate drug which given directly intrathecally so it has direct effect on brain and its metabolism ,as Methotrexate is one of antifolate drugs our results were similar to that stated by Kaemingk et al.,(2004)who study two groups one ALL patients received only chemotherapy(including intrathecal methotrexate)and healthy control ,it was founded that there is mathematics difficulties in ALL group compared to control group ,this as seen in our study in significant quantitative difference between cases and control, as Quantitative IQ represents an individual's store of acquired mathematical knowledge ( McGrew,2009) . It is stated that mathematics is very sensitive to any change in white matter (McGrew, 2009 (2002) showed a greater neurotoxic effect of chemotherapy or cranial radiation or both when given to the younger patient as white matter development continues up to 20 years this explain our results as significant difference in verbal subscale was found between younger and older age groups among studied cases. Therefore, those who are younger at treatment generally have less fully developed white matter so as early beginning intrathecal treatment as more white matter loss as more neurocognitive function defects. However, since both younger and older patients have been shown to lose white matter at similar rates (Reddick et al., 2000) , the younger irradiated patients or who received intrathecal chemotherapy continue to display reduced total white matter volume following either treatment. These deficits in white matter volume among younger patients have also been associated with increased intellectual morbidity (Mulhern et al., 2001).
There is excellent outcome for most forms of childhood and adolescent NHL Patients with localized disease have a 90-100% chance of survival, and those with advanced disease have a 70-95% chance of survival. As outcomes for pediatric patients with NHL have improved substantially, the focus has now shifted to minimizing the long-term toxicity of therapy (lanzkowskey et al, 2016).
In a study named Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt at the Pediatric Oncology Unit of Zagazig University Hospital and the Benha Specialized Pediatric Hospital, it is founded Complete remission was achieved in (84.5%), (11.3%) of them succumbed to the disease (relapse) during the first few months and (4.2%) remained alive following relapse. The mean followup duration ± SD was 34.6±25.1 months .The 5-year overall survival (OS) and event-free survival (EFS) rates were 88.7 and 85.1%, respectively (LAILA M. SHERIEF et al, 2015).
Summary
Methotrexate has harmful adverse effect on congnitive functions of children treated for NHL (in verbal and quantitative subscales), and this effect increases when MTX treatment started at younger age.
